A Phase I/II Open-Label Study to Evaluate the Safety and Efficacy of Orally Administered Full-Spectrum Medicinal Cannabis Plant Extract 0.08% THC (FEN164) in Children with Autism Spectrum Disorder.

Project: Research

Project Details

StatusActive
Effective start/end date27/10/2126/11/26

Keywords

  • Phase 1 and 2 study
  • treatment efficacy
  • treatment safety
  • autism